Evidence map›Paper›PMID 12554904›Full record

ReviewThorax2003

Pharmacotherapy and airway remodelling in asthma?

P A Beckett, P H Howarth

Abstract readReview
In one paragraph

Review in Thorax, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma.American journal of respiratory and critical care medicine · 2006
    Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2012
    Article
  14. Role of hyaluronan and hyaluronan-binding proteins in human asthma.The Journal of allergy and clinical immunology · 2011
    Article
  15. Airway remodeling: a potential therapeutic target in asthma.World journal of pediatrics : WJP · 2011
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

P A BeckettRespiratory Cell Molecular Biology Division, Southampton General Hospital, Southampton SO16 6YD, UK. Pab@soton.ac.uk
P H Howarth

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last few decades attention has largely focused on airway inflammation in asthma, but more recently it has been appreciated that there are important structural airway changes which have been grouped together under the term "airway remodelling". It is only now that questions have been asked about the impact of treatment on these structural changes. This review examines the nature of these structural airway changes, the mechanisms of their generation, their potential consequences, and what is known about the ability of anti-asthma treatments to modulate these changes.

Indexed as

Adrenal Cortex HormonesAdrenergic beta-AgonistsAdultAgedAirway ObstructionAnti-Asthmatic AgentsAsthmaBronchiBronchitisChromonesExtracellular Matrix ProteinsFemaleFibroblastsForced Expiratory VolumeHumansHyperplasiaAdrenal Cortex HormonesAdrenergic beta-AgonistsAnti-Asthmatic AgentsChromonesExtracellular Matrix ProteinsImmunosuppressive AgentsLeukotrienes

Identifiers

PMID12554904
PMCPMC1746582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.